Open cell foam associated with a second open cell foam
US-2015374560-A1 · Dec 31, 2015 · US
US2018133358A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018133358-A1 |
| Application number | US-201615576139-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 26, 2016 |
| Priority date | May 27, 2015 |
| Publication date | May 17, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A polyurethane foam wound dressing, the foam integrally comprising an oxidoreductase enzyme and a substrate for the enzyme. The foam is produced by mixing a polyurethane polymer, water, an oxidoreductase enzyme and substrate for the enzyme and drying the resulting product.
Opening claim text (preview).
1 . A polyurethane foam wound dressing, the foam integrally comprising an oxidoreductase enzyme and a substrate for the oxidoreductase enzyme. 2 . The foam wound dressing of claim 1 , wherein the oxidoreductase enzyme is glucose oxidase and the substrate is glucose, the oxidoreductase enzyme is fructose oxidase and the substrate is fructose, the oxidoreductase enzyme is hexose oxidase and the substrate is a hexose sugar, the oxidoreductase enzyme is cholesterol oxidase and the substrate is cholesterol, the oxidoreductase enzyme is galactose oxidase and the substrate is galactose, the oxidoreductase enzyme is pyranose oxidase and the substrate is pyranose, the oxidoreductase enzyme is choline oxidase and the substrate is choline, the oxidoreductase enzyme is pyruvate oxidase and the substrate is pyruvate or the oxidoreductase enzyme is glycollate oxidase and the substrate is glycollate. 3 . The foam wound dressing of claim 1 , wherein the foam has a density of at least 0.28 g/cm 3 and comprises at least 0.1 mg enzyme per gram of foam, and at least 1% (w/w) of substrate. 4 . The foam wound dressing of claim 1 , wherein the foam is produced by mixing a polyurethane polymer, water, an oxidoreductase enzyme and a substrate for the oxidoreductase enzyme to produce a resulting product; and drying the resulting product. 5 . The foam wound dressing of claim 4 , wherein a monohydric alcohol and/or a rubber is added when producing the foam. 6 . A method of producing a polyurethane foam wound dressing comprising mixing a polyurethane polymer, water, an oxidoreductase enzyme and a substrate for the oxidoreductase enzyme to produce a resulting product; and drying the resulting product. 7 . The method of claim 6 , wherein a monohydric alcohol is added when producing the foam. 8 . The method of claim 6 , wherein the polyurethane polymer is an isocyanate-capped prepolymer. 9 . The method of claim 7 , wherein the monohydric alcohol is methanol. 10 . The method of claim 6 , wherein a rubber is added when producing the foam. 11 . The method of claim 6 , wherein the oxidoreductase enzyme is glucose oxidase and the substrate is glucose, the oxidoreductase enzyme is fructose oxidase and the substrate is fructose, the oxidoreductase enzyme is hexose oxidase and the substrate is a hexose sugar, the oxidoreductase enzyme is cholesterol oxidase and the substrate is cholesterol, the oxidoreductase enzyme is galactose oxidase and the substrate is galactose, the oxidoreductase enzyme is pyranose oxidase and the substrate is pyranose, the oxidoreductase enzyme is choline oxidase and the substrate is choline, the oxidoreductase enzyme is pyruvate oxidase and the substrate is pyruvate or the oxidoreductase enzyme is glycollate oxidase and the substrate is glycollate. 12 . The method of claim 6 , wherein the drying is carried out at over 50° C. and below 100° C., including between 60° C. to 80° C. 13 . A polyurethane foam wound dressing obtained or obtainable according to the method of claim 6 . 14 . A polyurethane foam wound dressing, the foam integrally comprising glucose and glucose oxidase, wherein the foam is produced by mixing an isocyanate-capped prepolymer, water, methanol and an aqueous acrylic polymer emulsion to form a mixture and drying the mixture at between 60° C. and 100° C. for at least 5 minutes. 15 . (canceled) 16 . A method of treating a wound comprising applying the polyurethane foam wound dressing of claim 1 or to a wound site. 17 . The foam wound dressing of claim 3 , comprising 0.1 mg to 1 mg enzyme per gram of foam. 18 . The foam wound dressing of claim 3 , comprising 5-20% of substrate. 19 . The method of claim 10 , wherein the rubber is an aqueous acrylic polymer emulsion. 20 . The method of claim 12 , herein the is carried out between 60° C. to 80° C.
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)} · CPC title
containing enzymes · CPC title
Porous materials, e.g. foams or sponges · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.